Results 151 to 160 of about 4,325,962 (256)

Unlocking antitumor immunity with adenosine receptor blockers. [PDF]

Cancer Drug Resist, 2023
Remley VA, Linden J, Bauer TW, Dimastromatteo J.   +3 more
europepmc   +1 more source

ABEL-FRET bridges the timescale gap in single-molecule measurements of the structural dynamics in the A_2A adenosine receptor. [PDF]

Commun Chem
Maslov I, Borshchevskiy V, Pérez I, Cherezov V, Hofkens J, Hendrix J, Börsch M, Gensch T.   +7 more
europepmc   +1 more source

A2A adenosine receptor protects tumors from antitumor T cells

Proceedings of the National Academy of Sciences of the United States of America, 2006
A. Ohta, E. Gorelik, S. Prasad, F. Ronchese, D. Lukashev, M. Wong, Xiaojun Huang, Sheila Caldwell, Ke-Bin Liu, Patrick T. Smith, Jiang-Fan Chen, E. Jackson, S. Apasov, S. Abrams, M. Sitkovsky   +14 more
semanticscholar   +1 more source

Therapeutic potential of adenosine receptor modulators in cancer treatment. [PDF]

RSC Adv
Maity P, Ganguly S, Deb PK.
europepmc   +1 more source

Adenosine Receptor mRNA Expression in Frontal Cortical Neurons in Schizophrenia. [PDF]

Cells, 2023
Sahay S, Devine EA, McCullumsmith RE, O'Donovan SM.   +3 more
europepmc   +1 more source

Applying Deep-Learning-Driven <i>De Novo</i> Design to Hit Identification: A Case Study on A_2A Adenosine Receptor Antagonists. [PDF]

J Med Chem
Persico M, Micoli A, Salmaso V, Cianciulli A, Moro S, Spalluto G, Buccioni M, Marucci G, Volpini R, Pozzan A, Micheli F, Federico S.   +11 more
europepmc   +1 more source

Evaluating 7‑Aminopyrazolo[4,3‑<i>d</i>]pyrimidines as Human A₁ and A₃ Adenosine Receptor Antagonists. [PDF]

ACS Omega
Georgiou K, Lamprakopoulou M, Buthmann H, Böing S, Pousias A, Dexter A, Chew EXY, Huang X, Michalettou EI, Pearce A, Dotsikas Y, Pouli N, Marakos P, Kolocouris A, Ladds G, Lougiakis N.   +15 more
europepmc   +1 more source

Adenosine A2A receptor as a drug discovery target.

Journal of Medicinal Chemistry, 2014
Manuel de Lera Ruiz, Yeon-Hee Lim, Junying Zheng   +2 more
semanticscholar   +1 more source

The long march towards testing the adenosine receptor agonism hypothesis for human cerebroprotection: The story of the A₁R/A₃R receptor agonist AST-004. [PDF]

Purinergic Signal
Liston TE, Korinek WS, Jacobson KA, Lechleiter JD.   +3 more
europepmc   +1 more source

Molecular basis of ligand binding and receptor activation at the human A₃ adenosine receptor. [PDF]

Nat Commun
Zhang L, Mobbs JI, Bennetts FM, Venugopal H, Nguyen ATN, Christopoulos A, van der Es D, Heitman LH, May LT, Glukhova A, Thal DM.   +10 more
europepmc   +1 more source